(Q34291177)

1 August 2017

1 reference

title

The role of CD30 in atopic disease (English)

1 reference

1 August 2017

Bengtsson A

1

1 reference

1 August 2017

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

56

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

593-603

1 reference

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Hodgkin's disease: a tumor with disturbed immunological pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

High proliferative activity of Reed Sternberg associated antigen Ki-1 positive cells in normal lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Cultured human NK cells express the Ki-1/CD30 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Serum levels of soluble CD30 in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

T helper cell differentiation in immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Th1 and Th2 in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Functional subsets of allergen-reactive human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Are T cells in rheumatoid synovium aggressors or bystanders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Th1-type immunity is incompatible with successful pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Atopic dermatitis: new insights and opportunities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Update on therapy of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

The immunologic and genetic basis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Different serum interleukin-12 and sCD30 levels in food- and pollen-sensitized children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

CD30-mediated signaling promotes the development of human T helper type 2-like T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

CD30 ligand in lymphoma patients with CD30+ tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Cross-linking of CD30 induces HIV expression in chronically infected T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

The role of lymphocytes in allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months' duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Crosslinking of CD30 on activated human Th clones enhances their cytokine production and downregulates the CD30 expression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

CD30 ligand is expressed on resting normal and malignant human B lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83+ dendritic cells expresses HLA-G as a membrane-bound and soluble protein

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Regulation of murine B cell growth and differentiation by CD30 ligand

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Expression of CD30 and nerve growth factor-receptor in neoplastic and reactive vascular lesions: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Soluble cytokine receptor CD30 in atopic disorders: a case-control study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Acute infectious mononucleosis. CD30 (Ki-1) antigen expression and histologic correlations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Ber-H2 expression in testicular germ cell tumors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

CD30 expression in seminoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Th1 versus Th2 responses in AIDS

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

CD30 and type 2 T helper (Th2) responses.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

In vivo relevance of CD30 in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Soluble CD30 in pediatric patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Cutaneous CD30+ cells in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Expression of CD30 on T helper cells in the inflammatory infiltrate of acute atopic dermatitis but not of allergic contact dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Circulating skin-homing T cells in atopic dermatitis. Selective up-regulation of HLA-DR, interleukin-2R, and CD30 and decrease after combined UV-A and UV-B phototherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Allergen-induced CD30 expression on T cells of atopic asthmatics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Spontaneous CD30 mRNA expression in peripheral blood mononuclear cells from atopic patients with high IgE serum levels

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Local expansion of allergen-specific CD30+Th2-type gamma delta T cells in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

IL-12 receptor beta2 and CD30 expression in paranasal sinus mucosa of patients with chronic sinusitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Soluble CD30 and cyclosporine in severe atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Soluble CD30 and CD23 in cord blood are not related to atopy in early childhood

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Prostaglandin and cytokine release by trophoblastic villi

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00137.X

7 January 2021

10.1034/J.1398-9995.2001.00137.X

Identifiers

DOI

1 reference

1 August 2017

1 reference